104
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Patient perspectives on the impact of acromegaly: results from individual and group interviews

, , &
Pages 53-62 | Published online: 09 Jan 2014

References

  • MelmedSMedical progress: acromegalyN Engl J Med2006355242558257317167139
  • AdelmanDTLiebertKJNachtigallLBLamersonMBakkerBAcromegaly: the disease, its impact on patients, and managing the burden of long-term treatmentInt J Gen Med20136313823359786
  • SannoNTeramotoAOsamuraRYPathology of pituitary tumorsNeurosurg Clin N Am20031412539 vi12690977
  • HoldawayIMRajasooryaCEpidemiology of acromegalyPituitary199921294111081170
  • ChansonPSalenaveSKamenickyPCazabatLYoungJPituitary tumours: acromegalyBest Pract Res Clin Endocrinol Metab200923555557419945023
  • SherlockMAyukJTomlinsonJWMortality in patients with pituitary diseaseEndocr Rev201031330134220086217
  • RajasooryaCHoldawayIMWrightsonPScottDJIbbertsonHKDeterminants of clinical outcome and survival in acromegalyClin Endocrinol (Oxf)1994411951028050136
  • KatznelsonLAtkinsonJLCookDMEzzatSZHamrahianAHMillerKKAmerican Association of Clinical EndocrinologistsAmerican Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly – 2011 updateEndocr Pract201117Suppl 414421846616
  • BarkerFGKlibanskiASwearingenBTranssphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volumeJ Clin Endocrinol Metab200388104709471914557445
  • Somatuline® Depot (lanreotide) [prescribing Information]Basking Ridge, NJ:Ipsen Biopharmaceuticals, Inc.2013
  • Sandostatin® LAR Depot (octreotide acetate) [prescribing information]East Hanover, NJNovartis Pharmaceuticals Corporation2011
  • RowlesSVPrietoLBadiaXShaletSMWebbSMTrainerPJQuality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaireJ Clin Endocrinol Metab20059063337334115755865
  • WebbSMBadiaXSurinachNLSpanish AcroQoL Study GroupValidity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective studyEur J Endocrinol2006155226927716868140
  • T’SjoenGBexMMaiterDVelkeniersBAbsRHealth-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegalyEur J Endocrinol2007157441141717893254
  • BiermaszNRPereiraAMSmitJWRomijnJARoelfsemaFMorbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of lifeJ Clin Endocrinol Metab20059052731273915741257
  • WassenaarMJBiermaszNRKloppenburgMClinical osteoarthritis predicts physical and psychological QoL in acromegaly patientsGrowth Horm IGF Res201020322623320194043
  • Acromegaly community [homepage on the Internet] Available from: http://www.acromegalycommunity.comAccessed December 24, 2013
  • SiegelSStreetz-van der WerfCSchottJSNolteKKargesWKreitschmann-AndermahrIDiagnostic delay is associated with psychosocial impairment in acromegalyPituitary201316450751423179964